Expert Insights on Triple-Negative Breast Cancer: Preparing for the Next Wave of Treatments

Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP, discussed the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Greene, Heather R., Schwartzberg, Lee S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857324/
https://www.ncbi.nlm.nih.gov/pubmed/33598323
http://dx.doi.org/10.6004/jadpro.2020.11.3.10
Descripción
Sumario:Heather R. Greene, MSN, FNP, AOCNP®, and Lee S. Schwartzberg, MD, FACP, discussed the current and future treatment landscape for triple-negative breast cancer, including recent and emerging data on approved treatments, novel therapeutic options being investigated, and best practices for identifying and monitoring adverse events associated with PARP and immune checkpoint inhibitors at JADPRO Live 2019.

Ejemplares similares